Press Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
11/28/2018
8:00 AM ET
Press Release

Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy

11/28/2018

NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor...

 Continue Reading
11/13/2018
4:20 PM ET
Earnings Release

Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

11/13/2018

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor...

 Continue Reading
10/30/2018
8:00 AM ET
Press Release

Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope

10/30/2018

First-of-its-kind Phase 1 clinical trial using intraventricular delivery of CAR T cells to brains of patients with HER2-positive breast cancer with brain metastases now enrolling patients

F...

 Continue Reading
Displaying 1 to 5 (of 47 releases)